The "2016 Clinical Research Site Award" to the Hematology-Oncology Unit

for "continued commitment to helping develop the medicines people need"

INC Research awarded the Hematology-Oncology Unit of the Department of Clinical Therapeutics of the School of Medicine of the National and Kapodistrian Uniersity of 皇冠比分网_皇冠即时比分-专为体育打造 with the "2016 Clinical Research Site Award" for "continued commitment to helping develop the medicines people need". INC is one of the leading Contract Research Organization (CRO) offering end to end solutions for professional clinical trials around the world. With 6,600 staff operating in over 110 countries across six continents worldwide, INC is operating 1,176 studies in 44,549 centers with 347,849 patients.

INC was named "best CRO" 2015 for its capacity to "keep up with the changing needs of our environment" and to be "an agent in driving positive change in the clinical development process".

This important recognition of excellence was awarded to the Hematology-Oncology Unit of the Department of Clinical Therapeutics?among more than 44,000 collaborative medical centers of INC. The Unit?has also had an ISO 9000 for the "design and performance of clinical trials" since 2012 and is considered as a center of excellence for clinical trials worldwide.

---